Want to join the conversation?
Brian Alexander of Raymond James asks if the company is still expecting constant currency revenue growth for all of FY16 adjusting for the H3C divestiture. $HPE said it still expect to see revenue growth for the total year in constant currency, but the growth rates will be a bit more normalized in 2H16.
Biodefense therapeutics firm $PIP announced an all-stock merger with biotech Altimmune. The respective boards of the two companies unanimously approved the merger.
$YHOO is reporting today after market close. Nobody cares about this stock.